Hester Biosciences Valuation Multiples

Hester Biosciences is valued at $213M as of November 2026, a 6.2x revenue multiple. In the last fiscal year, Hester Biosciences revenue was $36M and Hester Biosciences EBITDA was $11M.

Hester Biosciences Overview

About Hester Biosciences

Hester Biosciences Ltd is an India-based animal healthcare company. It is principally engaged in the manufacturing of veterinary vaccines and trading of veterinary health products such as goat pox vaccine, PPR vaccines, etc. The group has two principal operating and reporting segments, viz. Poultry healthcare and Animal healthcare. Maximum revenue is generated from the Poultry Healthcare segment, which offers various solutions encompassing vaccines, health products, and feed supplements, supported and packaged by its diagnostic services, R&D, quality standards, and field support, to help farmers protect flock health, enhance productivity, and drive long-term farm sustainability. Geographically, it generates maximum revenue within India, and also exports its products to other markets.


Founded

1987

HQ

India

Employees

562

Website

hester.in

Financials (Last FY)

Revenue: $36M
EBITDA: $11M

EV

$220M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Hester Biosciences Financials

Hester Biosciences reported last fiscal year revenue of $36M and EBITDA of $11M.

In the same fiscal year, Hester Biosciences generated $26M in gross profit, $11M in EBITDA, and $6M in net income.


Hester Biosciences P&L

In the most recent fiscal year, Hester Biosciences reported revenue of $36M and EBITDA of $11M.

Hester Biosciences is profitable as of last fiscal year, with gross margin of 72%, EBITDA margin of 30%, and net margin of 17%.

See analyst estimates for Hester Biosciences
Last FY202620272028
Revenue$36M
Gross Profit$26M
Gross Margin72%
EBITDA$11M
EBITDA Margin30%
EBIT Margin23%
Net Profit$6M
Net Margin17%
Net Debt$20M

Financial data powered by Morningstar, Inc.

Hester Biosciences Stock Performance

Hester Biosciences has current market cap of $213M, and enterprise value of $220M.

Market Cap Evolution


Hester Biosciences' stock price is $25.00.

Hester Biosciences has an EPS (earnings per share) of $0.70.

See more trading valuation data for Hester Biosciences
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$220M$213M0.5%---$0.70

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Hester Biosciences Valuation Multiples

Hester Biosciences trades at 6.2x EV/Revenue multiple, and 20.4x EV/EBITDA.

See NTM and 2027E valuation multiples for Hester Biosciences

Hester Biosciences Financial Valuation Multiples

As of November 19, 2026, Hester Biosciences has market cap of $213M and EV of $220M.

Hester Biosciences has a P/E ratio of 35.7x.

Last FY202620272028
EV/Revenue6.2x
EV/EBITDA20.4x
EV/EBIT26.6x
EV/Gross Profit8.6x
P/E35.7x
EV/FCF51.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Hester Biosciences Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Hester Biosciences Margins & Growth Rates

In the most recent fiscal year, Hester Biosciences reported gross margin of 72%, EBITDA margin of 30%, and net margin of 17%.

See estimated margins and future growth rates for Hester Biosciences

Hester Biosciences Margins

Last FY202720282029
Gross Margin72%
EBITDA Margin30%
EBIT Margin23%
Net Margin17%
FCF Margin12%

Data powered by FactSet, Inc. and Morningstar, Inc.

Hester Biosciences Operational KPIs

Hester Biosciences' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for Hester Biosciences
Last FY202620272028
Revenue per Employee$0.1M
Opex per Employee$0.0M
S&M Expenses to Revenue8%
Opex to Revenue48%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Hester Biosciences Competitors

Hester Biosciences competitors include Racura Oncology, Lineage Cell Therapeutics, Newron Pharmaceuticals, Tanvex BioPharma, AC Immune, Oryzon Genomics, Celon Pharma, Yarrow Bioscience, Transgene and Bicycle Therapeutics.

Most Hester Biosciences public comparables operate across Biopharmaceuticals, Life Sciences Tools and BioTech.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Racura Oncology$2M($8M)94.0x94.0x(24.6x)(55.1x)
Lineage Cell Therapeutics$15M($70M)11.5x17.9x(2.4x)(5.2x)
Newron Pharmaceuticals$21M($9M)10.4x19.0x(23.9x)(6.8x)
Tanvex BioPharma$12M($34M)21.5x20.7x(7.6x)-
AC Immune$4M($83M)29.4x5.1x(1.5x)-
Oryzon Genomics-($6M)-30.8x(32.5x)(23.4x)
Celon Pharma$48M$4M4.9x3.5x57.6x28.6x
Yarrow Bioscience------

This data is available for Pro users. Sign up to see all Hester Biosciences competitors and their valuation data.

Start Free Trial

Acquisitions by Hester Biosciences

Hester Biosciences has acquired 1 company to date.

Last acquisition by Hester Biosciences was on November 21st 2014. Hester Biosciences acquired Gujarat Agrofarm Ltd. for $84K (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Hester Biosciences

Gujarat Agrofarm Ltd.
Description
Gujarat Agrofarm Ltd. is an Ahmedabad-based manufacturer in Gujarat, India. It produces microbial growth media, tissue culture nutrients, and agar-based substrates for agriculture and biotechnology labs. The company supplies ready-to-use plates and powdered formulations for plant propagation, mushroom cultivation, and bacterial culturing. Its products support sericulture, horticulture, and research institutes across western India.
HQ CountryIndia
HQ City
Ahmedabad
Deal Date21 Nov 2014
Valuation$84K
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Hester Biosciences acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Hester Biosciences

When was Hester Biosciences founded?Hester Biosciences was founded in 1987.
Where is Hester Biosciences headquartered?Hester Biosciences is headquartered in India.
How many employees does Hester Biosciences have?As of today, Hester Biosciences has over 562 employees.
Is Hester Biosciences publicly listed?Yes, Hester Biosciences is a public company listed on Bombay Stock Exchange.
What is the stock symbol of Hester Biosciences?Hester Biosciences trades under 524669 ticker.
When did Hester Biosciences go public?Hester Biosciences went public in 2015.
Who are competitors of Hester Biosciences?Hester Biosciences main competitors include Racura Oncology, Lineage Cell Therapeutics, Newron Pharmaceuticals, Tanvex BioPharma, AC Immune, Oryzon Genomics, Celon Pharma, Yarrow Bioscience, Transgene, Bicycle Therapeutics.
What is the current market cap of Hester Biosciences?Hester Biosciences' current market cap is $213M.
What is the current revenue of Hester Biosciences?Hester Biosciences' last fiscal year revenue is $36M.
What is the current EV/Revenue multiple of Hester Biosciences?Current revenue multiple of Hester Biosciences is 6.2x.
Is Hester Biosciences profitable?No, Hester Biosciences is not profitable.
How many companies Hester Biosciences has acquired to date?As of November 2026, Hester Biosciences has acquired 1 company.
What was the largest acquisition by Hester Biosciences?$84K acquisition of Gujarat Agrofarm Ltd. on 21st November 2014 was the largest M&A Hester Biosciences has done to date.
What companies Hester Biosciences acquired?Hester Biosciences acquired Gujarat Agrofarm Ltd..
In how many companies Hester Biosciences has invested to date?Hester Biosciences hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Hester Biosciences

Lists including Hester Biosciences

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial